Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Credit Suisse Group AG 

Amedisys Inc. diskutieren

Amedisys Inc.

WKN: 915582 / Symbol: AMED / Name: Amedisys / Aktie / Anbieter & Dienstleistungen / Mid Cap /

86,00 €
1,78 %

Einschätzung Buy
Rendite (%) -0,58 %
Kursziel 108,15
Veränderung
Endet am 28.02.24

Amedisys, Inc. (NASDAQ: AMED) had its "outperform" rating re-affirmed by analysts at Credit Suisse Group AG. They now have a $115.00 price target on the stock.
Ratings data for AMED provided by MarketBeat

Amedisys, Inc. (NASDAQ: AMED) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for AMED provided by MarketBeat

Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for AMED provided by MarketBeat

Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for AMED provided by MarketBeat

Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for AMED provided by MarketBeat

Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for AMED provided by MarketBeat

Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for AMED provided by MarketBeat

Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for AMED provided by MarketBeat

Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for AMED provided by MarketBeat

Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for AMED provided by MarketBeat

Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for AMED provided by MarketBeat

Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for AMED provided by MarketBeat

Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for AMED provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,38 %
Kursziel 92,26
Veränderung
Endet am 25.03.25

Amedisys, Inc. (NASDAQ: AMED) had its price target raised by analysts at Royal Bank of Canada from $97.00 to $100.00. They now have an "outperform" rating on the stock.
Ratings data for AMED provided by MarketBeat

Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for AMED provided by MarketBeat

Amedisys, Inc. (NASDAQ: AMED) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for AMED provided by MarketBeat